​

Vaxart (VXRT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VXRT Stock Forecast

Vaxart (VXRT) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a 177.78% increase from the last price of $0.72.

High: $2 Avg: $2 Low: $2 Last Closed Price: $0.72

VXRT Stock Rating

Vaxart stock's rating consensus is Hold, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (33.33%), 2 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 3 0 2 1 Strong Sell Sell Hold Buy Strong Buy

VXRT Forecast vs Benchmarks

TypeNameUpside
StockVaxart177.78%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$2.00
Last Closing Price$0.72$0.72$0.72
Upside/Downside--177.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-4---4
Dec, 24-4---4
Nov, 2424---6
Oct, 2424---6
Sep, 2424---6
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 31, 2024Mayank MamtaniB.Riley Financial$2.00$1.1869.49%177.78%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2024OppenheimerOutperformHoldinitialise
Aug 14, 2024OppenheimerOutperforminitialise
Dec 19, 2022B. Riley SecuritiesNeutralNeutralhold
Jun 12, 2021Piper SandlerOverweightinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.36$-0.58$-0.84$-0.57-----
Avg Forecast$-0.28$-0.66$-0.84$-0.59$-0.39$-0.38$-0.43$-0.40$-0.46
High Forecast$-0.55$-1.32$-1.67$-0.66$-0.40$-0.54$-0.69$-1.62$-0.82
Low Forecast$-0.06$-0.14$-0.17$-0.56$-0.36$-0.27$-0.28$0.25$-0.09
Surprise %28.57%-12.12%--3.39%-----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.05M$892.00K$107.00K$7.38M-----
Avg Forecast$8.05M$993.25K$792.50K$4.24M$34.30M$39.00M$50.20M$171.70M$146.50M
High Forecast$3.15M$388.54K$309.19K$3.92M$13.51M$15.13M$19.48M$66.63M$56.85M
Low Forecast$14.19M$1.75M$1.40M$4.57M$69.84M$62.87M$80.92M$276.78M$236.15M
Surprise %-49.74%-10.19%-86.50%73.84%-----

Net Income Forecast

$-250M $-190M $-130M $-70M $-10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-32.22M$-70.47M$-107.76M$-82.47M-----
Avg Forecast$-26.33M$-67.35M$-83.47M$-82.47M$-54.56M$-58.65M$-96.47M$-22.33M$-65.89M
High Forecast$-31.59M$-80.82M$-100.16M$-98.96M$-57.43M$-78.20M$-100.51M$-235.28M$-118.31M
Low Forecast$-21.06M$-53.88M$-66.77M$-65.97M$-51.69M$-39.10M$-40.79M$36.60M$-13.47M
Surprise %22.39%4.63%29.10%------

VXRT Forecast FAQ

Is Vaxart stock a buy?

Vaxart stock has a consensus rating of Hold, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vaxart is a neutral investment for most analysts.

What is Vaxart's price target?

Vaxart's price target, set by 3 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential 177.78% change from the previous close price of $0.72.

How does Vaxart stock forecast compare to the average forecast of its sector, industry, and investment themes?

Vaxart stock forecast shows a 177.78% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Vaxart over the past three months?

  • January 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Vaxart’s EPS forecast?

Vaxart's average annual EPS forecast for its fiscal year ending in December is -0.39 for 2024, a -31.58% decrease from the reported $-0.57 in 2023. The prediction for 2025 is $-0.38, $-0.43 for 2026, $-0.4 for 2027, and $-0.46 for 2028.

What is Vaxart’s revenue forecast?

Vaxart's average annual revenue forecast for its fiscal year ending in December is $34.3M for 2024, a 364.83% increase from the reported $7.38M in 2023. The forecast for 2025 is $39M, $50.2M for 2026, $171.7M for 2027, and $146.5M for 2028.

What is Vaxart’s net income forecast?

For its fiscal year ending in December, Vaxart's average annual net income forecast is $-54.562M for 2024, reflecting a -33.84% decrease from the reported $-82.465M in 2023. The projection for 2025 is $-58.652M, $-96.468M for 2026, $-22.325M for 2027, and $-65.893M for 2028.